<h1>Infant receives life-saving Zolgensma gene therapy for rare SMA Type 1 after parents crowdfund INR 8.41 crore</h1> An infant from West Bengal diagnosed with Spinal Muscular Atrophy Type 1 successfully received Zolgensma gene therapy after parents raised INR 8.41 crore through crowdfunding platform. The campaign attracted 5.29 lakh donors, setting a record for highest donor participation on the platform. SMA Type 1 is a rare genetic disorder caused by SMN1 gene mutation that weakens muscles and impairs vital functions, often fatal within two years if untreated. Zolgensma provides one-time gene therapy replacing the faulty gene with functional copy, offering potential for long-term recovery and normal development.